ATLANTA, Ga.,
19
June
2018
|
13:00 PM
Europe/Amsterdam

Team Novo Nordisk Announces Partnership with Dexcom - the Global Leader in Continuous Glucose Monitoring Systems

The San Diego-based company will provide cutting-edge continuous glucose monitoring systems to the world’s first all-diabetes pro cycling team

Team Novo Nordisk, the world’s first all-diabetes professional cycling team, and Dexcom, a global leader in development, manufacturing, and distribution of continuous glucose monitoring systems for diabetes management, announced a partnership that provides products to continuously monitor blood glucose levels to athletes on Team Novo Nordisk’s men’s professional team.

Phil Southerland, CEO & Co-Founder of Team Novo Nordisk
Dexcom's continuous glucose monitoring devices are a big reason why Team Novo Nordisk can inspire, educate, and empower people with diabetes so consistently as we race around the globe. Together, we will continue to change diabetes for years to come.
Phil Southerland, CEO & Co-Founder of Team Novo Nordisk

“I am thrilled to announce the partnership with Dexcom. Since they launched, they have shown their commitment to people with diabetes and commitment to innovation. This has reshaped how we live and dream with diabetes,” said Team Novo Nordisk CEO and Co-Founder Phil Southerland. “Dexcom's continuous glucose monitoring devices are a big reason why Team Novo Nordisk can inspire, educate, and empower people with diabetes so consistently as we race around the globe. Our riders have been using their products for years, and we look forward to developing a long-term partnership. Together, we will continue to change diabetes for years to come.”

Founded in 1999, Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes. Over the past two decades, Dexcom has made extensive progress on behalf of people with diabetes. Since their inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class—while empowering the community to take control of their diabetes.

“Dexcom’s mission is to empower people to take control of diabetes with our continuous glucose monitoring device,” said Kevin Sayer, President and Chief Executive Officer of Dexcom. “It just so happens that Team Novo Nordisk’s mission is to inspire, educate and empower people affected by diabetes, which makes them a perfect partner to team up with. By constantly tracking their levels with the Dexcom CGM System, the cyclists can focus on the race, rather than on their diabetes. We’re rooting for them and can’t wait to see how they do!”

Phil Southerland, CEO & Co-Founder of Team Novo Nordisk
Since Dexcom launched, they have shown their commitment to people with diabetes and commitment to innovation. This has reshaped how we live and dream with diabetes. 
Phil Southerland, CEO & Co-Founder of Team Novo Nordisk
About Team Novo Nordisk – Racing to Change Diabetes

Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world’s first all-diabetes UCI Professional Continental cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. 

For more information, go to www.teamnovonordisk.com.

 

All photos courtesy of ©KL_Photo.